ACE and myocardial infarction: Notably, prevention of VA in the postacute phase of MI remains an area of active investigation, with data suggesting that the use of antiplatelet agents, angiotensin‐converting enzyme inhibitors, or statins may reduce the subsequent arrhythmic risk [16, 17, 18].